CGI Receives Approval to Provide Oncology Testing for Patients in California
News Jan 05, 2015
Cancer Genetics, Inc has announced that its CLIA-certified, CAP-accredited reference laboratory has received licensure from the California Department of Health. The California Clinical Laboratory License will allow the company to provide its state-of-the art oncology testing services for patient samples from the state of California.
"Approval to provide our comprehensive oncology tests and services throughout California opens up the single largest US oncology diagnostics market to CGI, and will help accelerate our commercial growth. CGI is well positioned to continue to empower the personalization of treatment by providing our unique technologies and tests for a region that demands innovation and access to world-class medical technology," said Panna Sharma, CEO of Cancer Genetics. "Although cancer rates in the State of California are relatively stable, there is a tremendous need to improve the costs associated with patient management and therapeutic selection, and provide molecular insights that can enable earlier and more comprehensive diagnosis. We will work closely with our partners, and with our sales and commercial team, to add value for clinicians, cancer centers, and regional providers to enable better, more informed diagnosis and prognosis of cancer."
In 2014, more than 171,000 new cases of cancer were diagnosed in the State of California, representing more than 10 percent of the total cancer incidence in the United States. The company believes that its proprietary tests and complete programs for Non-Hodgkin's Lymphoma (NHL) and leukemia will be of particular benefit to California, where more than 6,800 new patients are diagnosed with NHL, and 4,300 additional patients are diagnosed with leukemia each year.
The Ancient Behaviour of Sleep, Conserved Throughout EvolutionNews
The finding that jellyfish sleep implies that sleep is an ancient behavior, largely untouched by millennia of evolution.READ MORE
Gene Immunotherapy Approach Prevents and Reverses Symptoms of Multiple SclerosisNews
Researchers used a viral vector to deliver a gene encoding a myelin sheath protein to the liver, thereby inducing robust and durable immune tolerance in mice by preventing T cells from attacking the myelin sheath.READ MORE
Genetic Code of Neuronal Communication Determines Cell TypeNews
The findings should help scientists sort out the bewildering array of neurons that are intertwined in the brain.READ MORE